We take ownership of our actions, decisions and outcomes. We honor our commitments, hold ourselves and others to high standards, and continuously strive to earn trust through transparency, integrity, and follow-through.
About us
Prolium is a clinical-stage biotechnology company focused on bringing breakthrough therapy to patients with autoimmune diseases. Established in 2025 and backed by RTW Investments in New York City, we are led by seasoned entrepreneurs and clinicians with deep experience in drug development.
Meet the Team
Our Values (ARCH)
At Prolium, we embody our values in everything we do.
We approach challenges with creativity, agility, and determination. We find smart, effective solutions with the tools at hand, adapt quickly to change, and turn obstacles into opportunities through innovation and initiative.
We believe that honest conversations, strong teamwork, and genuine connection fuel our success. We speak openly and respectfully, work together across boundaries, and foster a culture of camaraderie where every voice is heard, and every person feels valued.
We value diverse perspectives, listen with curiosity, and treat every interaction as a chance to learn and grow. Respect and humility guide our actions, no matter our experience or title.